Lead Exposure and Association with Angiogenic Factors and Hypertensive Disorders of Pregnancy
-
2020/10/01
-
Details
-
Personal Author:Erlinger AL ; Hacker MR ; Hart JM ; Hauptman M ; Johnson KM ; Karumanchi SA ; O'Brien K ; Salahuddin S ; Specht AJ ; Woolf AD ; Wylie BJ
-
Description:Objectives: Lead exposure has been associated with hypertensive disorders of pregnancy. Angiogenic factors, including soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF), are aberrant in preeclampsia, but have not been correlated with lead levels. We evaluated the association of lead exposure with angiogenic factors. Study design: This cross sectional study utilized a convenience sample of singleton pregnancies ≥34 weeks' gestation. Blood lead and angiogenic factors were measured before delivery; bone lead was measured postpartum. We dichotomized bone and blood lead into the top tertile versus the bottom tertiles and used log-binomial regression to assess the association between lead and a high angiogenic ratio. Main outcome measures: The outcomes were high sFlt1 to PlGF ratio and development of a hypertensive disorder of pregnancy. Results: We enrolled 102 participants, of whom 98 had at least one lead measurement and an angiogenic factor result. Median bone lead was 3.8 ug/g (2.0 - 6.6) and median blood lead was 0.2 ug/dL (0.2 - 0.4). Incidence of hypertensive disorders of pregnancy was 31%. When comparing the highest tertile of bone lead to the bottom two tertiles, there was no association with a high sFlt1/PlGF ratio or hypertensive disorders of pregnancy. Similar results were observed for the exposure of blood lead. Conclusions: Lead exposure was not an important contributor to an elevated angiogenic factor ratio or hypertensive disorders of pregnancy in our U.S. population. However, lead exposure was modest in our population and we cannot exclude a relationship with hypertensive disorders of pregnancy. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:2210-7789
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:93-98
-
Volume:22
-
NIOSHTIC Number:nn:20062237
-
Citation:Pregnancy Hypertens 2020 Oct; 22:93-98
-
Contact Point Address:Katherine M. Johnson, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Kirstein 3, Boston, MA 02215, USA
-
Email:katherine.m.johnson07@gmail.com
-
CAS Registry Number:
-
Federal Fiscal Year:2021
-
NORA Priority Area:
-
Performing Organization:Harvard School of Public Health, Boston, Massachusetts
-
Peer Reviewed:False
-
Start Date:20190901
-
Source Full Name:Pregnancy Hypertension
-
End Date:20220831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e0e8647ba6c23dd01ca24f75ade10d5ab169449b57bb13f419c983febc98669226152a30361686d28c109fa0cae9d45890a453162ec79a9e2b5f67ae6f11d28b
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like